Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay C R, Qin S, Lanzavecchia A
Basel Institute for Immunology, Switzerland.
Eur J Immunol. 1998 Sep;28(9):2760-9. doi: 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N.
Dendritic cells (DC) migrate into inflamed peripheral tissues where they capture antigens and, following maturation, to lymph nodes where they stimulate T cells. To gain insight into this process we compared chemokine receptor expression in immature and mature DC. Immature DC expressed CCR1, CCR2, CCR5 and CXCR1 and responded to their respective ligands, which are chemokines produced at inflammatory sites. Following stimulation with LPS or TNF-alpha maturing DC expressed high levels of CCR7 mRNA and acquired responsiveness to the CCR7 ligand EBI1 ligand chemokine (ELC), a chemokine produced in lymphoid organs. Maturation also resulted in up-regulation of CXCR4 and down-regulation of CXCR1 mRNA, while CCR1 and CCR5 mRNA were only marginally affected for up to 40 h. However, CCR1 and CCR5 were lost from the cell surface within 3 h, due to receptor down-regulation mediated by chemokines produced by maturing DC. A complete down-regulation of CCR1 and CCR5 mRNA was observed only after stimulation with CD40 ligand of DC induced to mature by LPS treatment. These different patterns of chemokine receptors are consistent with "inflammatory" and "primary response" phases of DC function.
树突状细胞(DC)迁移至炎症外周组织,在那里摄取抗原,成熟后再迁移至淋巴结,在淋巴结中刺激T细胞。为深入了解这一过程,我们比较了未成熟和成熟DC中趋化因子受体的表达情况。未成熟DC表达CCR1、CCR2、CCR5和CXCR1,并对其各自的配体产生反应,这些配体是在炎症部位产生的趋化因子。在用脂多糖(LPS)或肿瘤坏死因子-α(TNF-α)刺激后,成熟DC表达高水平的CCR7信使核糖核酸(mRNA),并获得了对CCR7配体EBI1配体趋化因子(ELC,一种在淋巴器官中产生的趋化因子)的反应能力。成熟还导致CXCR4上调和CXCR1 mRNA下调,而CCR1和CCR5 mRNA在长达40小时内仅受到轻微影响。然而,由于成熟DC产生的趋化因子介导的受体下调,CCR1和CCR5在3小时内从细胞表面消失。仅在用LPS处理诱导成熟的DC的CD40配体刺激后,才观察到CCR1和CCR5 mRNA的完全下调。这些趋化因子受体的不同模式与DC功能的“炎症”和“初级反应”阶段一致。